Multiple Human Papilloma Virus Infections and Their Impact on the Development of High-Risk Cervical Lesions

Acta Cytologica

Volumn 59, Issue 5, 2015, Pages 391-398

  Salazar, Katrina L ^a   Zhou, Haijun Steve ^a   Xu, Jiaqiong ^a   Peterson, Leif E ^a   Schwartz, Mary R ^a   Mody, Dina R ^a,b   Ge, Yimin ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cervical cancer; Cervical dysplasia; Human papillomavirus; Intergenotypic interaction; Multiple human papillomavirus infections

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICES; DISEASE ASSOCIATION; DNA MICROARRAY; FEMALE; GENOTYPE; HIGH RISK CERVICAL LESION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS DNA TEST; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VAGINA SMEAR KIT; VERY ELDERLY; WART VIRUS; AGE DISTRIBUTION; CLASSIFICATION; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; GENETICS; MIDDLE AGED; MIXED INFECTION; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; CERVICAL INTRAEPITHELIAL NEOPLASIA; COINFECTION; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84955754615     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000442512     Document Type: Article

References (39)

1. Pater MM, Dunne J, Hogan G, et al. Human papillomavirus types 16 and 18 sequences in early cervical neoplasia. Virology 1986;155:13-18.
2. Biological Agents. Volume 100 B. A Review of Human Carcinogens. IARC Monogr Eval Carcinog Risks Hum. Lyon, IARC, 2012, vol 100B, pp 1-441.
3. Mendez F, Munoz N, Posso H, et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005;192:1158-1165.
4. Vaccarella S, Franceschi S, Herrero R, et al. Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis 2011;204:385-390.
5. Thomas KK, Hughes JP, Kuypers JM, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000;182:1097-1102.
6. Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001;183:8-15.
7. Rousseau MC, Pereira JS, Prado JC, et al. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001;184:1508-1517.
8. Chaturvedi AK, Myers L, Hammons AF, et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005;14:2439-2445.
9. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57:68-72.
10. Dickson EL, Vogel RI, Bliss RL, et al. Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology. Int J Gynecol Cancer 2013;23:1295-1302.
11. Huang LW, Chao SL, Chen PH, et al. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J Clin Virol 2004;29:271-276.
12. Mejlhede N, Bonde J, Fomsgaard A: High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 2009;117:108-114.
13. Bello BD, Spinillo A, Alberizzi P, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 2009;81:703-712.
14. Fife KH, Cramer HM, Schroeder JM, et al. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001;64:550-559.
15. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005;191:1796-1807.
16. Lee SA, Kang D, Seo SS, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett 2003;198:187-192.
17. Pista A, Oliveira A, Verdasca N, et al. Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women. Clin Microbiol Infect 2011;17:941-946.
18. Spinillo A, dal Bello B, Gardella B, et al. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Gynecol Oncol 2009;113:115-119.
19. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006;15:1274-1280.
20. Chaturvedi AK, Katki HA, Hildesheim A, et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011;203:910-920.
21. Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002;40:3341-3345.
22. Rositch AF, Poole C, Hudgens MG, et al. Multiple human papillomavirus infections and type competition in men. J Infect Dis 2012;205:72-81.
23. Wentzensen N, Nason M, Schiffman M, et al. No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. J Infect Dis 2014;209:855-864.
24. Wheeler CM, Hunt WC, Schiffman M, et al. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006;194:1291-1299.
25. Sobota RS, Ramogola-Masire D, Williams SM, et al. Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer. Infect Agent Cancer 2014;9:26.
26. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-1423.
27. Plummer M, Schiffman M, Castle PE, et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007;195:1582-1589.
28. Vaccarella S, Franceschi S, Snijders PJ, et al. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010;19:503-510.
29. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-477.
30. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-474.
31. Luostarinen T, af Geijersstam V, Bjorge T, et al. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int J Cancer 1999;80:818-822.
32. Silins I, Wang Z, Avall-Lundqvist E, et al. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Virol 1999;80(pt 11):2931-2936.
33. Chaturvedi AK, Dumestre J, Gaffga AM, et al. Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol 2005;75:105-113.
34. Levi JE, Fernandes S, Tateno AF, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004;92:225-231.
35. Arcavi L, Benowitz NL: Cigarette smoking and infection. Arch Intern Med 2004;164:2206-2216.
36. Poppe WA, Ide PS, Drijkoningen MP, et al. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 1995;39:34-38.
37. Sedlacek TV: Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol 1999;42:206-220.
38. Malagon T, Drolet M, Boily MC, et al. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:781-789.
39. Zhou H, Schwartz MR, Coffey DM, et al. Genotype-specific prevalence and distribution of human papillomavirus genotypes in underserved Latino women with abnormal Papanicolaou tests. J Am Soc Cytopathol 2014;4:42-48.